BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Corbacioglu S, Jabbour EJ, Mohty M. Risk Factors for Development of and Progression of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome. Biology of Blood and Marrow Transplantation 2019;25:1271-80. [DOI: 10.1016/j.bbmt.2019.02.018] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 12.3] [Reference Citation Analysis]
Number Citing Articles
1 Corbacioglu S, Topaloglu O, Aggarwal S. A Systematic Review and Meta-Analysis of Studies of Defibrotide Prophylaxis for Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome. Clin Drug Investig 2022. [PMID: 35594010 DOI: 10.1007/s40261-022-01140-y] [Reference Citation Analysis]
2 Schenone L, Houillier C, Tanguy ML, Choquet S, Agbetiafa K, Ghesquières H, Damaj G, Schmitt A, Bouabdallah K, Ahle G, Gressin R, Cornillon J, Houot R, Marolleau J, Fornecker L, Chinot O, Peyrade F, Bouabdallah R, Moluçon-chabrot C, Gyan E, Chauchet A, Casasnovas O, Oberic L, Delwail V, Abraham J, Roland V, Waultier-rascalou A, Willems L, Morschhauser F, Fabbro M, Ursu R, Thieblemont C, Jardin F, Tempescul A, Malaise D, Touitou V, Nichelli L, Le Garff-tavernier M, Plessier A, Bourget P, Bonmati C, Wantz-mézières S, Giordan Q, Dorvaux V, Charron C, Jabeur W, Hoang-xuan K, Taillandier L, Soussain C, Houillier C, Choquet S, Hoang-xuan K, Touitou V, Soussain C, Cassoux N, Malaise D, Ursu R, Willems L, Ghesquières H, Schmitt A, Chinot O, Tabouret E, Taillandier L, Blonski M, Houot R, Ahle G, Damaj G, Moluçon-chabrot C, Delwail V, Fabbro M, Jardin F, Chauchet A, Morschhauser F, Casasnovas O, Gressin R, Fornecker L, Abraham J, Marolleau J, Tempescul A, Agapé P, Oberic L, Gyan E, Peyrade F, Gastinne T; on behalf of the French network for oculocerebral lymphoma (LOC network). Intensive chemotherapy followed by autologous stem cell transplantation in primary central nervous system lymphomas (PCNSLs). Therapeutic outcomes in real life—experience of the French Network. Bone Marrow Transplant. [DOI: 10.1038/s41409-022-01648-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Myers AL. VOD/SOS and Alkylating Agents in the Hematopoietic Stem Cell Transplant Setting: New Insights and Further Questions. Transplantation and Cellular Therapy 2022;28:179-80. [DOI: 10.1016/j.jtct.2022.03.001] [Reference Citation Analysis]
4 Saleh K, Fernandez A, Pasquier F. Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in Adults. Cancers 2022;14:1805. [DOI: 10.3390/cancers14071805] [Reference Citation Analysis]
5 Bonnet C, Dupuis J, Tilly H, Lamy T, Fruchart C, le Gouill S, Thieblemont C, Morschhauser F, Casasnovas O, Bouabdallah K, Ghesquieres H, Van Den Neste E, André M, Cartron G, Salles G. Ibrutinib Associated with Rituximab-Platinum Salt-Based Immunochemotherapy in B-Cell Lymphomas: Results of a Phase 1b-II Study of the LYSA Group. Cancers (Basel) 2022;14:1761. [PMID: 35406532 DOI: 10.3390/cancers14071761] [Reference Citation Analysis]
6 Robin S, Hassine KB, Muthukumaran J, Jurkovic Mlakar S, Krajinovic M, Nava T, Uppugunduri CRS, Ansari M. A potential implication of UDP-glucuronosyltransferase 2B10 in the detoxification of drugs used in pediatric hematopoietic stem cell transplantation setting: an in silico investigation. BMC Mol and Cell Biol 2022;23. [DOI: 10.1186/s12860-021-00402-5] [Reference Citation Analysis]
7 Tilmont R, Yakoub-Agha I, Ramdane N, Srour M, Coiteux V, Magro L, Odou P, Simon N, Beauvais D. Impact of Defibrotide in the Prevention of Acute Graft-Versus-Host Disease Following Allogeneic Hematopoietic Cell Transplantation. Ann Pharmacother 2022;:10600280211068177. [PMID: 35016532 DOI: 10.1177/10600280211068177] [Reference Citation Analysis]
8 Kozanoglu I, Pepedil-tanrikulu F. Functions of the endothelium and its role in hematopoietic cell transplantation. Transfusion and Apheresis Science 2022. [DOI: 10.1016/j.transci.2022.103368] [Reference Citation Analysis]
9 Miyamoto T, Domoto R, Sekiguchi F, Kamaguchi R, Nishimura R, Matsuno M, Tsubota M, Fujitani M, Hatanaka S, Koizumi Y, Wang D, Nishibori M, Kawabata A. Development of hepatic impairment aggravates chemotherapy-induced peripheral neuropathy following oxaliplatin treatment: Evidence from clinical and preclinical studies. Journal of Pharmacological Sciences 2022. [DOI: 10.1016/j.jphs.2022.01.006] [Reference Citation Analysis]
10 Bognàr T(, Bartelink I(H, Egberts T(, Rademaker C(, Versluys B(B, Slatter M(A, Kletzel M(, Nath C(E, Cuvelier G(, Savic R(M, Dvorak C(, Long-boyle J(R, Cowan M(J, Bittencourt H(, Bredius R(GM, Güngör T(, Shaw P(J, Ansari M(, Hassan M(, Krajinovic M(, Hempel G(, Marktel S(, Chiesa R(, Théoret Y(, Lund T(, Orchard P(, Wynn R(F, Boelens JJ(, Lalmohamed A(. Association between the magnitude of intravenous busulfan exposure and development of hepatic veno-occlusive disease in children and young adults undergoing myeloablative allogeneic hematopoietic cell transplantation. Transplantation and Cellular Therapy 2022. [DOI: 10.1016/j.jtct.2022.01.013] [Reference Citation Analysis]
11 Özkan SG, Özkan HA. Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation in adult patients: diagnosis, incidence, prophylaxis, and treatment. Transfusion and Apheresis Science 2022. [DOI: 10.1016/j.transci.2022.103372] [Reference Citation Analysis]
12 Ravaioli F, Marconi G, Martinelli G, Dajti E, Sartor C, Abbenante MC, Alemanni LV, Nanni J, Rossini B, Parisi S, Colecchia L, Cristiano G, Marasco G, Vestito A, Paolini S, Bonifazi F, Curti A, Festi D, Cavo M, Colecchia A, Papayannidis C. Assessment of liver stiffness measurement and ultrasound findings change during inotuzumab ozogamicin cycles for relapsed or refractory acute lymphoblastic leukemia. Cancer Med 2021. [PMID: 34970853 DOI: 10.1002/cam4.4390] [Reference Citation Analysis]
13 Sato M, Yasunaga M, Ohzu M, Toyama K, Nakazaki K, Nakahara F, Kubo T, Okura N, Abe O, Kurokawa M. Successful diagnosis of veno-occlusive disease caused by inotuzumab ozogamicin through minimal-invasive angiography: a case report. Ann Hematol 2021. [PMID: 34859286 DOI: 10.1007/s00277-021-04713-7] [Reference Citation Analysis]
14 Lange AP, Usmani AA, Wald C, Gordon FD. Sinusoidal Obstruction Syndrome in a Young Woman With Antiphospholipid Syndrome on Oral Contraceptives. Hepatology 2021;74:3539-41. [PMID: 34219254 DOI: 10.1002/hep.32041] [Reference Citation Analysis]
15 Walker SM, Selers EL, Jay MA; Great Ormond Street Hospital Inpatient Pain Service. Intravenous opioids for chemotherapy-induced severe mucositis pain in children: Systematic review and single-center case series of management with patient- or nurse-controlled analgesia (PCA/NCA). Paediatr Anaesth 2021. [PMID: 34731511 DOI: 10.1111/pan.14324] [Reference Citation Analysis]
16 O'Hagan Henderson S, Frietsch JJ, Hilgendorf I, Hochhaus A, Köhne CH, Casper J. Combination of treosulfan, fludarabine and cytarabine as conditioning in patients with acute myeloid leukemia, myelodysplastic syndrome and myeloproliferative neoplasms. J Cancer Res Clin Oncol 2021. [PMID: 34674031 DOI: 10.1007/s00432-021-03836-8] [Reference Citation Analysis]
17 Yoon JH, Choi CW, Won JH. Hepatic sinusoidal obstruction syndrome/veno-occlusive disease after hematopoietic cell transplantation: historical and current considerations in Korea. Korean J Intern Med 2021;36:1261-80. [PMID: 34555279 DOI: 10.3904/kjim.2021.082] [Reference Citation Analysis]
18 Qin H, Yang L, Chukinas JA, Shah N, Tarun S, Pouzolles M, Chien CD, Niswander LM, Welch AR, Taylor N, Tasian SK, Fry TJ. Systematic preclinical evaluation of CD33-directed chimeric antigen receptor T cell immunotherapy for acute myeloid leukemia defines optimized construct design. J Immunother Cancer 2021;9:e003149. [PMID: 34531250 DOI: 10.1136/jitc-2021-003149] [Reference Citation Analysis]
19 Izumi A, Tachibana T, Ando T, Tanaka M, Kanamori H, Nakajima H. A case series of patients treated with inotuzumab ozogamicin for acute lymphoblastic leukemia relapsed after allogeneic hematopoietic cell transplantation. Int J Hematol 2021. [PMID: 34490598 DOI: 10.1007/s12185-021-03217-4] [Reference Citation Analysis]
20 Bonifazi F, Sica S, Angeletti A, Marktel S, Prete A, Iori AP, Olivari D, Rossetti G, Bertaina A, Botti S, Busca A, Carella AM, Cerretti R, Gargiulo G, Grassi A, Gualandi F, Irrera G, Milone G, Risitano AM, Santarone S, Vassallo E, Zecca M, Ciceri F, Pomponio G. Veno-occlusive Disease in HSCT Patients: Consensus-based Recommendations for Risk Assessment, Diagnosis, and Management by the GITMO Group. Transplantation 2021;105:686-94. [PMID: 33273315 DOI: 10.1097/TP.0000000000003569] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Masetti R, Biagi E, Zama D, Muratore E, D'Amico F, Leardini D, Turroni S, Prete A, Brigidi P, Pession A. Early modifications of the gut microbiome in children with hepatic sinusoidal obstruction syndrome after hematopoietic stem cell transplantation. Sci Rep 2021;11:14307. [PMID: 34253759 DOI: 10.1038/s41598-021-93571-4] [Reference Citation Analysis]
22 Mohty M, Battista ML, Blaise D, Calore E, Cesaro S, Maximova N, Perruccio K, Renard C, Wynn R, Zecca M, Labopin M, Hanvesakul R, Amber V, Ryan RJ, Lawson S, Ciceri F. A multicentre, multinational, prospective, observational registry study of defibrotide in patients diagnosed with veno-occlusive disease/sinusoidal obstruction syndrome after haematopoietic cell transplantation: an EBMT study. Bone Marrow Transplant 2021. [PMID: 34059801 DOI: 10.1038/s41409-021-01265-2] [Reference Citation Analysis]
23 Schulz M, Vuong LG, Müller HP, Maibier M, Tacke F, Blau IW, Wree A. Shear Wave Elastography in the Detection of Sinusoidal Obstruction Syndrome in Adult Patients Undergoing Allogenic Hematopoietic Stem Cell Transplantation. Diagnostics (Basel) 2021;11:928. [PMID: 34064217 DOI: 10.3390/diagnostics11060928] [Reference Citation Analysis]
24 Hotta M, Satake A, Yoshimura H, Fujita S, Katayama Y, Ota S, Hanamoto H, Oyake T, Ito S, Okada M, Nakanishi T, Ito T, Ishii K, Nomura S. Elevation of Early Plasma Biomarkers in Patients with Clinical Risk Factors Predicts Increased Nonrelapse Mortality after Allogeneic Hematopoietic Stem Cell Transplantation. Transplant Cell Ther 2021;27:660.e1-8. [PMID: 33989832 DOI: 10.1016/j.jtct.2021.04.025] [Reference Citation Analysis]
25 Waespe N, Strebel S, Jurkovic Mlakar S, Krajinovic M, Kuehni CE, Nava T, Ansari M. Genetic Predictors for Sinusoidal Obstruction Syndrome-A Systematic Review. J Pers Med 2021;11:347. [PMID: 33925809 DOI: 10.3390/jpm11050347] [Reference Citation Analysis]
26 Lai X, Liu L, Zhang Z, Shi L, Yang G, Wu M, Huang R, Liu R, Lai Y, Li Q. Hepatic veno-occlusive disease/sinusoidal obstruction syndrome after hematopoietic stem cell transplantation for thalassemia major: incidence, management, and outcome. Bone Marrow Transplant 2021;56:1635-41. [PMID: 33608657 DOI: 10.1038/s41409-021-01233-w] [Reference Citation Analysis]
27 Xiao J, Tu J, Zhang H, Zhang F, Zhang W, Xu H, Yin Q, Yang J, Han H, Wang Y, Zhang B, Peng C, Zou X, Zhang M, Zhuge Y. Risk factors of poor prognosis in patients with pyrrolidine alkaloid-induced hepatic sinusoidal obstruction syndrome after transjugular intrahepatic portosystemic shunt. Hepatol Int 2021;15:720-9. [PMID: 33507485 DOI: 10.1007/s12072-020-10126-x] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
28 Gavralidis A, Brunner AM. Novel Therapies in the Treatment of Adult Acute Lymphoblastic Leukemia. Curr Hematol Malig Rep 2020;15:294-304. [PMID: 32445026 DOI: 10.1007/s11899-020-00591-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
29 Cook J, Litzow M. Advances in Supportive Care for Acute Lymphoblastic Leukemia. Curr Hematol Malig Rep 2020;15:276-93. [PMID: 32607955 DOI: 10.1007/s11899-020-00585-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
30 Bisbal M, Darmon M, Saillard C, Mallet V, Mouliade C, Lemiale V, Benoit D, Pene F, Kouatchet A, Demoule A, Vincent F, Nyunga M, Bruneel F, Lebert C, Renault A, Meert AP, Hamidfar R, Jourdain M, Azoulay E, Mokart D. Hepatic dysfunction impairs prognosis in critically ill patients with hematological malignancies: A post-hoc analysis of a prospective multicenter multinational dataset. J Crit Care 2021;62:88-93. [PMID: 33310587 DOI: 10.1016/j.jcrc.2020.11.023] [Reference Citation Analysis]
31 Orlando N, Babini G, Chiusolo P, Valentini CG, De Stefano V, Teofili L. Pre-Exposure to Defibrotide Prevents Endothelial Cell Activation by Lipopolysaccharide: An Ingenuity Pathway Analysis. Front Immunol 2020;11:585519. [PMID: 33343567 DOI: 10.3389/fimmu.2020.585519] [Reference Citation Analysis]
32 Zhao M, Xie J, Shen H, Wang X, Wu Q, Xia L. Role of endothelial-microparticles and the tissue factor pathway in ginsenoside Rb1-mediated prevention of umbilical vein endothelial cell injury. Biomed Rep 2021;14:8. [PMID: 33235723 DOI: 10.3892/br.2020.1384] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Ehrhardt MJ, Skinner R, Castellino SM. Renal and Hepatic Health After Childhood Cancer. Pediatr Clin North Am 2020;67:1203-17. [PMID: 33131542 DOI: 10.1016/j.pcl.2020.07.011] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
34 Goldenson BH, Goodman AM, Ball ED. Gemtuzumab ozogamicin for the treatment of acute myeloid leukemia in adults. Expert Opin Biol Ther 2021;21:849-62. [PMID: 32990476 DOI: 10.1080/14712598.2021.1825678] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
35 Kaloyannidis P, Omari R, Eldebawy E, Al Shaibani E, Apostolidis J, Hindi T, Raslan H, Al Garni A, Al Buali A, Al Anezi K, Al Hashmi H. Favorable Outcome After Adjuvant Involved-Field Radiotherapy After Autologous Hematopoietic Stem-Cell Transplantation in Patients With High-Risk Relapsed/Refractory Lymphoma: A Single-Center Experience. Clin Lymphoma Myeloma Leuk 2021;21:e112-9. [PMID: 33060051 DOI: 10.1016/j.clml.2020.08.028] [Reference Citation Analysis]
36 Ikezoe T. Advances in the diagnosis and treatment of disseminated intravascular coagulation in haematological malignancies. Int J Hematol 2021;113:34-44. [PMID: 32902759 DOI: 10.1007/s12185-020-02992-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
37 Gómez-Centurión I, Bailén R, Oarbeascoa G, Muñoz C, Luque AÁ, Boyra ME, Calleja E, Rincón D, Dorado N, Barzallo P, Anguita J, Díez-Martín JL, Kwon M. Transjugular Intrahepatic Portosystemic Shunt for Very Severe Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) after Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation with Post-transplantation Cyclophosphamide. Biol Blood Marrow Transplant 2020;26:2089-97. [PMID: 32791193 DOI: 10.1016/j.bbmt.2020.08.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
38 Fulcher J, Leung E, Christou G, Bredeson C, Sabloff M. Selecting the optimal targeted therapy for relapsed B-acute lymphoblastic leukemia. Leuk Lymphoma 2020;61:2271-3. [PMID: 32427017 DOI: 10.1080/10428194.2020.1761965] [Reference Citation Analysis]
39 Szmit Z, Gorczynska E, Król A, Ussowicz M, Mielcarek-Siedziuk M, Olejnik I, Panasiuk A, Kałwak K. Introduction of new pediatric EBMT criteria for VOD diagnosis: is it time-saving or money-wasting? : Prospective evaluation of pediatric EBMT criteria for VOD. Bone Marrow Transplant 2020;55:2138-46. [PMID: 32398785 DOI: 10.1038/s41409-020-0918-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
40 Zhang X, Thomas C, Schiano TD, Thung SN, Ward SC, Fiel MI. Aberrant von Willebrand factor expression of sinusoidal endothelial cells and quiescence of hepatic stellate cells in nodular regenerative hyperplasia and obliterative portal venopathy. Histopathology 2020;76:959-67. [PMID: 31994248 DOI: 10.1111/his.14083] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
41 Bonifazi F, Barbato F, Ravaioli F, Sessa M, Defrancesco I, Arpinati M, Cavo M, Colecchia A. Diagnosis and Treatment of VOD/SOS After Allogeneic Hematopoietic Stem Cell Transplantation. Front Immunol 2020;11:489. [PMID: 32318059 DOI: 10.3389/fimmu.2020.00489] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
42 Cairo MS, Cooke KR, Lazarus HM, Chao N. Modified diagnostic criteria, grading classification and newly elucidated pathophysiology of hepatic SOS/VOD after haematopoietic cell transplantation. Br J Haematol 2020;190:822-36. [PMID: 32133623 DOI: 10.1111/bjh.16557] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
43 Nava T, Ansari M, Dalle JH, de Heredia CD, Güngör T, Trigoso E, Falkenberg U, Bertaina A, Gibson B, Jarisch A, Balduzzi A, Boenig H, Krivan G, Vettenranta K, Matic T, Buechner J, Kalwak K, Lawitschka A, Yesilipek A, Lucchini G, Peters C, Turkiewicz D, Niinimäki R, Diesch T, Lehrnbecher T, Sedlacek P, Hutt D, Dalissier A, Wachowiak J, Yaniv I, Stein J, Yalçin K, Sisinni L, Deiana M, Ifversen M, Kuhlen M, Meisel R, Bakhtiar S, Cesaro S, Willasch A, Corbacioglu S, Bader P. Supportive care during pediatric hematopoietic stem cell transplantation: beyond infectious diseases. A report from workshops on supportive care of the Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 2020;55:1126-36. [PMID: 32029909 DOI: 10.1038/s41409-020-0818-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
44 Liu K, Tian LX, Tang X, Wang J, Tang WQ, Ma ZF, Chen T, Liang HP. Neutrophilic granule protein (NGP) attenuates lipopolysaccharide-induced inflammatory responses and enhances phagocytosis of bacteria by macrophages. Cytokine. 2020;128:155001. [PMID: 32035329 DOI: 10.1016/j.cyto.2020.155001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
45 Renaghan AD, Jaimes EA, Malyszko J, Perazella MA, Sprangers B, Rosner MH. Acute Kidney Injury and CKD Associated with Hematopoietic Stem Cell Transplantation. Clin J Am Soc Nephrol 2020;15:289-97. [PMID: 31836598 DOI: 10.2215/CJN.08580719] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
46 Tian L, Li X, Tang X, Zhou X, Luo L, Ma X, Tang W, Yu J, Ma W, Yang X, Yan J, Xu X, Liang H. Ellipticine Conveys Protective Effects to Lipopolysaccharide-Activated Macrophages by Targeting the JNK/AP-1 Signaling Pathway. Inflammation 2020;43:231-40. [DOI: 10.1007/s10753-019-01112-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
47 Chau CH, Steeg PS, Figg WD. Antibody–drug conjugates for cancer. The Lancet 2019;394:793-804. [DOI: 10.1016/s0140-6736(19)31774-x] [Cited by in Crossref: 123] [Cited by in F6Publishing: 52] [Article Influence: 41.0] [Reference Citation Analysis]
48 Maximova N, Caddeo G, Zanon D, Maestro A, Simeone R. Drop of Butyrylcholinesterase Activity after Cyclophosphamide Conditioning as a Predictive Marker of Liver Transplant-Related Complications and Its Correlation with Transplant-Related Mortality in Pediatric Hematopoietic Stem Cell Recipients. J Clin Med 2019;8:E825. [PMID: 31185690 DOI: 10.3390/jcm8060825] [Reference Citation Analysis]